Voices of Biotech

Deepa Talpade, Vice President, BD&L and Strategic Alliances of Oncology at Bayer discusses the socioeconomic impact deterring women to reach their full potential, the success of Bayer's I&D Xcelerate program, and the necessity to take a risk on women.

Ilona Gutcher, director of BD&L Oncology at Bayer discusses female role models within the industry and her experience as a graduate of Bayer's I&D Xcelerate program.

This episode of the Voices of Biotech - brought to you by the BioProcess Insider Expression Platform -brings you an in-depth conversation with Antoinette Gawin, CEO of Terumo Blood and Cell Technologies.

Gawin shares her personal experience of growing up within an immigrant farming community before entering the pharma space and climbing the career ladder. She talks about how people should not be afraid to show vulnerability in the workplace. Additionally, she discusses the importance of making sure all voices are heard, regardless of who the voices come from.

Jawa shares her career journey and the challenges in transitioning from academia to industry. “There is always a mindset that people from academia are not made for biotech or the pharmaceutical sector. So, it took me a while to get out of that academic mode,” says Jawa.

This leads her to highlight the importance of mentoring and developing a strong network of support at the beginning of your career, “I could’ve benefited initially with a better network which I did not have.”